Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Animal Rule's Study Designs For Anthrax Vaccine Show Utility For Other Products

Executive Summary

When an FDA advisory panel gave its enthusiastic backing to the strategy for anthrax vaccine research developed by the agency's Center for Biologics Evaluation and Research, it also provided an important precedent for future applications of the "animal rule," which allows sponsors to conduct animal trials when human clinical trials would be impractical or unethical.
Advertisement

Related Content

Smallpox Treatments: Are Monkeypox Or Mousepox Acceptable Substitutes For Studying The Virus?
FDA “Progressive Approval” And “Exceptional Approval” Pathways Possible Under Senate Bill
FDA “Progressive Approval” And “Exceptional Approval” Pathways Possible Under Senate Bill
FDA Moving Beyond Animal Rule To Animal Guidance With November Workshop
FDA Moving Beyond Animal Rule To Animal Guidance With November Workshop
FDA Panel Finds Animal Models Predict Human Response To HGS Anthrax Drug
Smallpox Drug Development May Get Boost From FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS052846

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel